BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Nifty Midcap 150

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty Midcap 150 Performance

Day's Range

Low

₹21,842.20

High

₹22,121.50

52 Week Range

Low

₹19,218.00

High

₹22,846.70

Previous Close ₹22,257.95
Day's Range ₹21,842.20 - ₹22,121.50
Open ₹22,116.20
52 Week Range ₹19,218.00 - ₹22,846.70
Volume 1,32,15,27,183

Nifty Midcap 150 Companies

Company Name LTP (₹) Change (₹) Sector
Blue Star Ltd. 1609.10 Arrow -48.90 (-2.95%) Consumer Durables
Exide Industries Ltd. 339.80 Arrow -9.25 (-2.65%) Automobile & Ancillaries
CRISIL Ltd. 4089.60 Arrow -48.00 (-1.16%) Ratings
Dabur India Ltd. 455.25 Arrow -12.45 (-2.66%) FMCG
Bharat Heavy Electricals Ltd. 389.65 Arrow -8.65 (-2.17%) Capital Goods
Hindustan Petroleum Corporation Ltd. 357.85 Arrow -8.55 (-2.33%) Crude Oil
Steel Authority Of India Ltd. 189.40 Arrow -3.00 (-1.56%) Iron & Steel
Godfrey Phillips India Ltd. 2316.80 Arrow -108.10 (-4.46%) FMCG
Godrej Industries Ltd. 1139.10 Arrow 4.05 (0.36%) Chemicals
Hero MotoCorp Ltd. 4951.00 Arrow -113.50 (-2.24%) Automobile & Ancillaries

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 23520.7 26373.20 22182.55
Nifty IT 28216.6 40301.40 27078.00
Nifty Next 50 68029.2 72037.60 59896.10
NIFTY50 USD Index 8463.8 10443.40 8132.40
Nifty Bank 53087.15 61764.85 49954.85
NIFTY Midcap 100 59880.0 62113.85 52032.85
Nifty 500 22311.85 24144.20 20385.65
Nifty Midcap 50 17093.3 17686.30 14804.55
Nifty 100 24386.55 26975.15 22720.45
Nifty FMCG 50615.5 58485.05 45334.15

Latest News

May
18
2026
EQUITY Posted on May 18th 2026

The Federal Bank informs about allotment of equity shares

The Federal Bank has informed that, as approved by the Nomination, Remuneration, Ethics and Compensation Committee, the following allotments have been made after payment of money by the allottees: 1. Allotment of 3,250 Equity Shares with face value of Rs. 2/- each of the Bank to the Option Grantees upon exercise of stock options under ESOS 2010 Scheme on May 17, 2026. 2. Allotment of 2,12,167 Equity Shares with face value of Rs. 2/- each of the Bank to the Option Grantees upon exercise of stock options under ESOS 2017 Scheme on May 17, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

One 97 Communications informs about press release

One 97 Communications has informed that it enclosed a press release titled as ‘Paytm Launches Pocket Money, Bringing Paytm UPI Payments to Teenagers Without a Bank Account’. This disclosure will also be hosted on the Company's website: https://ir.paytm.com/.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial. Glenmark’s Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial is bioequivalent and therapeutically equivalent to the reference listed drug, Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial of Fresenius Kabi USA, LLC. The company has attached media release.
The above information is a part of company’s filings submitted to BSE.
Read More
May
16
2026
EQUITY Posted on May 16th 2026

Cochin Shipyard informs about newspaper advertisements

Cochin Shipyard has informed that it enclosed copies of the newspaper advertisements published regarding audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
May
16
2026
EQUITY Posted on May 16th 2026

Aurobindo Pharma informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that: CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, announced that the Central Drugs Standard Control Organization (CDSCO) has granted Marketing Authorisation under Form CT 23 for Bevqolva®, a bevacizumab biosimilar indicated for metastatic carcinoma of the colon or rectum. The authorisation permits manufacture at CuraTeQ’s facility in Hyderabad and marketing of Bevqolva® in 100 mg/4mL and 400 mg/16 mL vial presentations.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NIFTYMIDCAP150 index?

The previous close of NIFTYMIDCAP150 index is ₹22000.35 as of 2026-05-18.

The total volume of NIFTYMIDCAP150 index is 1321527183.00 as of 2026-05-18.

The percentage change in value of NIFTYMIDCAP150 index is -1.16% as of 2026-05-18.

The absolute increase in NIFTYMIDCAP150 index value since the previous trading day is ₹-257.6 as of 2026-05-18.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore